Effects of Oral vs. Non-oral Contraceptives on the GH/IGF-1 Axis
Completed
Massachusetts General Hospital
Phase 4
2015-01-01
This study will determine whether the negative effects of combined oral contraceptive (COC)
therapy on the growth hormone/insulin-like growth factor-1 (GH/IGF-1) axis and bone turnover
are dependent on the route of administration such that an attenuation of these effects is
observed when a comparable dose of non-oral transdermal contraceptive (TDC) and contraceptive
vaginal ring therapy (CVR) are also tested.
Effects of Oral vs. Non-oral Contraceptives on the GH/IGF-1 Axis
Completed
Purdue University
Phase 4
2015-01-01
This study will determine whether the negative effects of combined oral contraceptive (COC)
therapy on the growth hormone/insulin-like growth factor-1 (GH/IGF-1) axis and bone turnover
are dependent on the route of administration such that an attenuation of these effects is
observed when a comparable dose of non-oral transdermal contraceptive (TDC) and contraceptive
vaginal ring therapy (CVR) are also tested.
Effects of Oral vs. Non-oral Contraceptives on the GH/IGF-1 Axis
Completed
Penn State University
Phase 4
2015-01-01
This study will determine whether the negative effects of combined oral contraceptive (COC)
therapy on the growth hormone/insulin-like growth factor-1 (GH/IGF-1) axis and bone turnover
are dependent on the route of administration such that an attenuation of these effects is
observed when a comparable dose of non-oral transdermal contraceptive (TDC) and contraceptive
vaginal ring therapy (CVR) are also tested.
Study Will Assess Skin Irritation and Sensitization for HP-1050 Patch
Recruiting
Noven Pharmaceuticals, Inc.
Phase 1
2020-11-03
A randomized, evaluator-blinded study to assess skin irritation and skin sensitization of
HP-1050 transdermal system (HP-1050) in comparison to XULANE patch in healthy female
volunteers.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
